Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

COX Inhibitors.

Qureshi O, Dua A.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.
2019 Dec 4.

2.

Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4+ T Cell Engulfment Process.

Davies SP, Reynolds GM, Wilkinson AL, Li X, Rose R, Leekha M, Liu YS, Gandhi R, Buckroyd E, Grove J, Barnes NM, May RC, Hubscher SG, Adams DH, Huang Y, Qureshi O, Stamataki Z.

Cell Rep. 2019 Nov 5;29(6):1610-1620.e4. doi: 10.1016/j.celrep.2019.09.068.

3.

CRISPR-Cas12a Nucleases Bind Flexible DNA Duplexes without RNA/DNA Complementarity.

Jiang W, Singh J, Allen A, Li Y, Kathiresan V, Qureshi O, Tangprasertchai N, Zhang X, Parameshwaran HP, Rajan R, Qin PZ.

ACS Omega. 2019 Oct 9;4(17):17140-17147. doi: 10.1021/acsomega.9b01469. eCollection 2019 Oct 22.

4.

Barriers and facilitators of mental health programmes in primary care in low-income and middle-income countries.

Esponda GM, Hartman S, Qureshi O, Sadler E, Cohen A, Kakuma R.

Lancet Psychiatry. 2020 Jan;7(1):78-92. doi: 10.1016/S2215-0366(19)30125-7. Epub 2019 Aug 29.

PMID:
31474568
5.

Adult Mouse Digit Amputation and Regeneration: A Simple Model to Investigate Mammalian Blastema Formation and Intramembranous Ossification.

Dawson LA, Brunauer R, Zimmel KN, Qureshi O, Falck AR, Kim P, Dolan CP, Yu L, Lin YL, Daniel B, Yan M, Muneoka K.

J Vis Exp. 2019 Jul 12;(149). doi: 10.3791/59749.

PMID:
31355793
6.

Spontaneous Extracellular Matrix Accumulation in a Human in vitro Model of Renal Fibrosis Is Mediated by αV Integrins.

Bon H, Hales P, Lumb S, Holdsworth G, Johnson T, Qureshi O, Twomey BM.

Nephron. 2019;142(4):328-350. doi: 10.1159/000499506. Epub 2019 May 2.

7.

Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model.

Rizvi SZH, Shah FA, Khan N, Muhammad I, Ali KH, Ansari MM, Din FU, Qureshi OS, Kim KW, Choe YH, Kim JK, Zeb A.

Int J Pharm. 2019 Apr 5;560:136-143. doi: 10.1016/j.ijpharm.2019.02.002. Epub 2019 Feb 10.

PMID:
30753932
8.

Measuring CTLA-4-Dependent Suppressive Function in Regulatory T Cells.

Hou TZ, Qureshi OS, Sansom DM.

Methods Mol Biol. 2019;1899:87-101. doi: 10.1007/978-1-4939-8938-6_7.

PMID:
30649767
9.

Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability.

Sajjad M, Khan MI, Naveed S, Ijaz S, Qureshi OS, Raza SA, Shahnaz G, Sohail MF.

AAPS PharmSciTech. 2019 Jan 15;20(2):81. doi: 10.1208/s12249-019-1297-z.

PMID:
30645705
10.

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.

Smith B, Kiessling A, Lledo-Garcia R, Dixon KL, Christodoulou L, Catley MC, Atherfold P, D'Hooghe LE, Finney H, Greenslade K, Hailu H, Kevorkian L, Lightwood D, Meier C, Munro R, Qureshi O, Sarkar K, Shaw SP, Tewari R, Turner A, Tyson K, West S, Shaw S, Brennan FR.

MAbs. 2018 Oct;10(7):1111-1130. doi: 10.1080/19420862.2018.1505464. Epub 2018 Sep 12.

11.

Blastema formation and periosteal ossification in the regenerating adult mouse digit.

Dawson LA, Schanes PP, Kim P, Imholt FM, Qureshi O, Dolan CP, Yu L, Yan M, Zimmel KN, Falck AR, Muneoka K.

Wound Repair Regen. 2018 May;26(3):263-273. doi: 10.1111/wrr.12666. Epub 2018 Oct 16.

PMID:
30120800
12.

Danger Changes the Way the Mammalian Brain Stores Information About Innocuous Events: A Study of Sensory Preconditioning in Rats.

Holmes NM, Raipuria M, Qureshi OA, Killcross S, Westbrook F.

eNeuro. 2018 Feb 14;5(1). pii: ENEURO.0381-17.2017. doi: 10.1523/ENEURO.0381-17.2017. eCollection 2018 Jan-Feb.

13.

Publisher Correction: Quantitative and organisational changes in mature extracellular matrix revealed through high-content imaging of total protein fluorescently stained in situ.

Holdsworth G, Bon H, Bergin M, Qureshi O, Paveley R, Atkinson J, Huang L, Tewari R, Twomey B, Johnson T.

Sci Rep. 2017 Dec 21;7(1):18111. doi: 10.1038/s41598-017-16513-z.

14.

A simple method for measuring immune complex-mediated, Fc gamma receptor dependent antigen-specific activation of primary human T cells.

Junker F, Krishnarajah S, Qureshi O, Humphreys D, Fallah-Arani F.

J Immunol Methods. 2018 Mar;454:32-39. doi: 10.1016/j.jim.2017.12.002. Epub 2017 Dec 16.

PMID:
29258749
15.

Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions.

Qureshi OS, Rowley TF, Junker F, Peters SJ, Crilly S, Compson J, Eddleston A, Björkelund H, Greenslade K, Parkinson M, Davies NL, Griffin R, Pither TL, Cain K, Christodoulou L, Staelens L, Ward E, Tibbitts J, Kiessling A, Smith B, Brennan FR, Malmqvist M, Fallah-Arani F, Humphreys DP.

Sci Rep. 2017 Dec 6;7(1):17049. doi: 10.1038/s41598-017-17255-8.

16.

Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.

Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A.

Int J Nanomedicine. 2017 Oct 5;12:7291-7309. doi: 10.2147/IJN.S146315. eCollection 2017. Review.

17.

An immunofluorescence assay for extracellular matrix components highlights the role of epithelial cells in producing a stable, fibrillar extracellular matrix.

Qureshi OS, Bon H, Twomey B, Holdsworth G, Ford K, Bergin M, Huang L, Muzylak M, Healy LJ, Hurdowar V, Johnson TS.

Biol Open. 2017 Oct 15;6(10):1423-1433. doi: 10.1242/bio.025866.

18.

Quantitative and organisational changes in mature extracellular matrix revealed through high-content imaging of total protein fluorescently stained in situ.

Holdsworth G, Bon H, Bergin M, Qureshi O, Paveley R, Atkinson J, Huang L, Tewari R, Twomey B, Johnson T.

Sci Rep. 2017 Aug 30;7(1):9963. doi: 10.1038/s41598-017-10298-x. Erratum in: Sci Rep. 2017 Dec 21;7(1):18111.

19.

Spinal Stenosis.

Raja A, Hoang S, Qureshi O, Mesfin FB.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.
2019 Dec 3.

20.

Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration.

Qureshi OS, Kim HS, Zeb A, Choi JS, Kim HS, Kwon JE, Kim MS, Kang JH, Ryou C, Park JS, Kim JK.

J Microencapsul. 2017 May;34(3):250-261. doi: 10.1080/02652048.2017.1337247. Epub 2017 Jun 15.

PMID:
28557649
21.

Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model.

Zeb A, Qureshi OS, Yu CH, Akram M, Kim HS, Kim MS, Kang JH, Majid A, Chang SY, Bae ON, Kim JK.

Int J Pharm. 2017 Jun 15;525(1):92-100. doi: 10.1016/j.ijpharm.2017.04.032. Epub 2017 Apr 18.

PMID:
28428089
22.

High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration.

Zeb A, Qureshi OS, Kim HS, Kim MS, Kang JH, Park JS, Kim JK.

J Pharm Pharmacol. 2017 Aug;69(8):955-966. doi: 10.1111/jphp.12727. Epub 2017 Apr 18.

PMID:
28421603
23.

Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signaling.

Adams R, Burnley RJ, Valenzano CR, Qureshi O, Doyle C, Lumb S, Del Carmen Lopez M, Griffin R, McMillan D, Taylor RD, Meier C, Mori P, Griffin LM, Wernery U, Kinne J, Rapecki S, Baker TS, Lawson AD, Wright M, Ettorre A.

Sci Rep. 2017 Jan 30;7:37716. doi: 10.1038/srep37716.

24.

Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery.

Qureshi OS, Zeb A, Akram M, Kim MS, Kang JH, Kim HS, Majid A, Han I, Chang SY, Bae ON, Kim JK.

Eur J Pharm Biopharm. 2016 Nov;108:187-195. doi: 10.1016/j.ejpb.2016.09.008. Epub 2016 Sep 12.

PMID:
27634645
25.

Islamic perspectives on clinical intervention near the end-of-life: We can but must we?

Padela AI, Qureshi O.

Med Health Care Philos. 2017 Dec;20(4):545-559. doi: 10.1007/s11019-016-9729-y.

PMID:
27613411
26.

Improved skin permeation of methotrexate via nanosized ultradeformable liposomes.

Zeb A, Qureshi OS, Kim HS, Cha JH, Kim HS, Kim JK.

Int J Nanomedicine. 2016 Aug 8;11:3813-24. doi: 10.2147/IJN.S109565. eCollection 2016.

27.

Prediction of quadruple hamstring graft diameter for anterior cruciate ligament reconstruction by anthropometric measurements.

Asif N, Ranjan R, Ahmed S, Sabir AB, Jilani LZ, Qureshi OA.

Indian J Orthop. 2016 Jan-Feb;50(1):49-54. doi: 10.4103/0019-5413.173521.

28.

Unstable Intertrochanteric Fracture Fixation - Is Proximal Femoral Locked Compression Plate Better Than Dynamic Hip Screw.

Asif N, Ahmad S, Qureshi OA, Jilani LZ, Hamesh T, Jameel T.

J Clin Diagn Res. 2016 Jan;10(1):RC09-13. doi: 10.7860/JCDR/2016/11179.7084. Epub 2016 Jan 1.

29.

A Nonsynonymous/Synonymous Substitution Analysis of the B56 Gene Family Aids in Understanding B56 Isoform Diversity.

Qureshi O, Cho H, Choudhary M, Seeling JM.

PLoS One. 2015 Dec 21;10(12):e0145529. doi: 10.1371/journal.pone.0145529. eCollection 2015.

30.

Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function.

Jeffery LE, Qureshi OS, Gardner D, Hou TZ, Briggs Z, Soskic B, Baker J, Raza K, Sansom DM.

PLoS One. 2015 Jul 2;10(7):e0131539. doi: 10.1371/journal.pone.0131539. eCollection 2015.

31.

Reviving a ghost in the history of technology: the social construction of the recumbent bicycle.

Ahmed H, Qureshi OM, Khan AA.

Soc Stud Sci. 2015 Feb;45(1):130-6.

PMID:
25803920
32.

A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells.

Hou TZ, Qureshi OS, Wang CJ, Baker J, Young SP, Walker LS, Sansom DM.

J Immunol. 2015 Mar 1;194(5):2148-59. doi: 10.4049/jimmunol.1401876. Epub 2015 Jan 28.

33.

A transendocytosis perspective on the CD28/CTLA-4 pathway.

Soskic B, Qureshi OS, Hou T, Sansom DM.

Adv Immunol. 2014;124:95-136. doi: 10.1016/B978-0-12-800147-9.00004-2. Review.

PMID:
25175774
34.

Road rage and road side accidents involvement in commercial vehicle drivers of Karachi.

Shaikh MA, Qureshi ON.

J Pak Med Assoc. 2014 Apr;64(4):481-2. No abstract available.

35.

IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells.

Attridge K, Kenefeck R, Wardzinski L, Qureshi OS, Wang CJ, Manzotti C, Okkenhaug K, Walker LS.

J Immunol. 2014 Mar 1;192(5):2195-201. doi: 10.4049/jimmunol.1302082. Epub 2014 Jan 27.

36.

Locked compression plating for peri- and intra-articular fractures around the knee.

Jain JK, Asif N, Ahmad S, Qureshi O, Siddiqui YS, Rana A.

Orthop Surg. 2013 Nov;5(4):255-60. doi: 10.1111/os.12069.

37.

Comparison of the intracellular trafficking itinerary of ctla-4 orthologues.

Kaur S, Qureshi OS, Sansom DM.

PLoS One. 2013;8(4):e60903. doi: 10.1371/journal.pone.0060903. Epub 2013 Apr 2.

38.

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses.

Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z, Kaur S, Raza K, Sansom DM.

J Immunol. 2012 Dec 1;189(11):5155-64. doi: 10.4049/jimmunol.1200786. Epub 2012 Oct 19.

39.

Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics.

Liaskou E, Zimmermann HW, Li KK, Oo YH, Suresh S, Stamataki Z, Qureshi O, Lalor PF, Shaw J, Syn WK, Curbishley SM, Adams DH.

Hepatology. 2013 Jan;57(1):385-98. doi: 10.1002/hep.26016. Epub 2012 Dec 4.

40.

Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells.

Wang CJ, Kenefeck R, Wardzinski L, Attridge K, Manzotti C, Schmidt EM, Qureshi OS, Sansom DM, Walker LS.

J Immunol. 2012 Aug 1;189(3):1118-22. doi: 10.4049/jimmunol.1200972. Epub 2012 Jun 29.

41.

Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation.

Qureshi OS, Kaur S, Hou TZ, Jeffery LE, Poulter NS, Briggs Z, Kenefeck R, Willox AK, Royle SJ, Rappoport JZ, Sansom DM.

J Biol Chem. 2012 Mar 16;287(12):9429-40. doi: 10.1074/jbc.M111.304329. Epub 2012 Jan 19.

42.

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.

Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z, Hou TZ, Futter CE, Anderson G, Walker LS, Sansom DM.

Science. 2011 Apr 29;332(6029):600-3. doi: 10.1126/science.1202947. Epub 2011 Apr 7.

43.

Response rates to standard interferon treatment in HCV genotype 3a.

Qureshi S, Batool U, Iqbal M, Qureshi O, Kaleem R, Aziz H, Azhar M.

J Ayub Med Coll Abbottabad. 2009 Oct-Dec;21(4):10-4.

PMID:
21067014
44.

A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitis.

Hou TZ, Bystrom J, Sherlock JP, Qureshi O, Parnell SM, Anderson G, Gilroy DW, Buckley CD.

FEBS Lett. 2010 Sep 24;584(18):3955-61. doi: 10.1016/j.febslet.2010.07.053. Epub 2010 Aug 2.

45.

Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN.

CMAJ. 2009 Dec 8;181(12):891-6. doi: 10.1503/cmaj.090784. Epub 2009 Dec 7.

46.

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K, Sansom DM.

J Immunol. 2009 Nov 1;183(9):5458-67. doi: 10.4049/jimmunol.0803217.

47.

Predictors of fatal outcome in acute myocardial infarction.

Shabbir M, Kayani AM, Qureshi O, Mughal MM.

J Ayub Med Coll Abbottabad. 2008 Jul-Sep;20(3):14-6.

PMID:
19610506
48.

Management of congenital talipes equinovarus by Ponseti technique: a clinical study.

Abbas M, Qureshi OA, Jeelani LZ, Azam Q, Khan AQ, Sabir AB.

J Foot Ankle Surg. 2008 Nov-Dec;47(6):541-5. doi: 10.1053/j.jfas.2008.07.002. Epub 2008 Sep 27.

PMID:
19239864
49.

Closure of patent ductus artriosus by transcatheter technique in a pregnant patient.

Shabbir M, Ahmed W, Qureshi O, Ali J.

J Pak Med Assoc. 2008 Dec;58(12):709-10.

50.

Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.

Schmidt EM, Wang CJ, Ryan GA, Clough LE, Qureshi OS, Goodall M, Abbas AK, Sharpe AH, Sansom DM, Walker LS.

J Immunol. 2009 Jan 1;182(1):274-82.

Supplemental Content

Loading ...
Support Center